🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Denmark / NCT06297447
Recruiting Not applicable

Keeping it Simple Study (KISS)

NCT06297447 · tracked via the Priya Life Science Denmark tracker
Sponsor
Bettina Eiger
Phase
Not applicable
Started
2024-03-11
Last updated
2024-12-27

Condition(s) studied

Musculoskeletal PainChronic Pain

Investigational drug(s) / intervention(s)

PNE4Adults - pain science educationUsual care

PNE4Adults - pain science education: Is formerly described under arm descriptions

Usual care: Is formerly described under arm descriptions

Study summary

Problem: The number of patients living with chronic musculoskeletal (MSK) pain has steadily increased over the past decade with costs rising equally. Long-standing pain is associated with significant maladaptive beliefs about pain, psychological characteristics and associated behaviors which involve structural and functional neurobiological characteristics which share common pathophysiological mechanisms as chronic pain. The investigators recent priority setting partnership investigated the research priorities from 1000 patients with chronic MSK pain, relatives, and clinicians. Better pain education was rated as one of the three most important research areas.

Solution: Pain science education has the potential to target maladaptive psychological and behavioral components that may contribute to the maintenance of chronic pain. The KISS project will evaluate the effect of a pain neuroscience education program (PNE4Adults) on rehabilitation outcomes in patients with chronic MSK pain. This intervention has the potential to change beliefs and behaviors surrounding pain in patients with chronic MSK pain. If this is successful in disrupting maladaptive cycles contributing to chronicity, this may improve outcomes for many thousand citizens.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients referred for rehabilitation in the municipalities Køge, Holbæk, and Solrød * With chronic (\>3 months) musculoskeletal pain. * Adult patients (≥18 years) - no upper limit * Able to understand, speak, and write Danish. Exclusion Criteria: * Known cognitive deficits (e.g., dementia). * Diagnosed with cancer or other serious pathologies, e.g., cauda equina. * Pregnancy * Drug addiction defined as the use of cannabis, opioids, or other drugs. * Neurologic or psychiatric diagnoses that hinder participation, e.g., stroke and borderline. * Lack of ability to cooperate.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Træningsenheden, Holbæk Municipality Holbæk Region Sjælland Recruiting
Træningsenheden, Køge Municipality Køge Region Sjælland Recruiting
Genoptræningscenteret, Solrød Municipality Solrød Strand Region Sjælland Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06297447 on ClinicalTrials.gov ↗ ← All trials in Denmark